These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31349108)

  • 21. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.
    Harskamp RE; Walker PF; Alexander JH; Xian Y; Liberman HA; de Winter RJ; Vassiliades TA; Peterson ED; Puskas JD; Halkos ME
    Am Heart J; 2014 Oct; 168(4):471-8. PubMed ID: 25262256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.
    Qintar M; Humphries KH; Park JE; Arnold SV; Tang Y; Jones P; Salisbury AC; Kureshi F; Farkouh ME; Fuster V; Cohen DJ; Spertus JA
    J Am Coll Cardiol; 2019 Oct; 74(16):2074-2084. PubMed ID: 31623766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Coronary Syndrome Revascularization Strategies With Multivessel Coronary Artery Disease.
    Widmer RJ; Hammonds K; Mixon T; Exaire JE; Chiles CD; Tavilla G; Szerlip MI; DiMaio JM
    Am J Cardiol; 2024 Jun; 220():33-38. PubMed ID: 38582315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease.
    Fink N; Nikolsky E; Assali A; Shapira O; Kassif Y; Barac YD; Finkelstein A; Eitan A; Danenberg H; Zahger D; Sahar G; Atar S; Raanani E; Bolotin G; Goldenberg I; Segev A
    Ann Thorac Surg; 2019 Jan; 107(1):106-111. PubMed ID: 30267693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life-long clinical outcome after the first myocardial revascularization procedures: 40-year follow-up after coronary artery bypass grafting and percutaneous coronary intervention in Rotterdam.
    Milojevic M; Thuijs DJFM; Head SJ; Domingues CT; Bekker MWA; Zijlstra F; Daemen J; de Jaegere PPT; Kappetein AP; van Domburg RT; Bogers AJJC
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):852-859. PubMed ID: 30753554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
    Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
    J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).
    Biancari F; Gudbjartsson T; Heikkinen J; Anttila V; Mäkikallio T; Jeppsson A; Thimour-Bergström L; Mignosa C; Rubino AS; Kuttila K; Gunn J; Wistbacka JO; Teittinen K; Korpilahti K; Onorati F; Faggian G; Vinco G; Vassanelli C; Ribichini F; Juvonen T; Axelsson TA; Sigurdsson AF; Karjalainen PP; Mennander A; Kajander O; Eskola M; Ilveskoski E; D'Oria V; De Feo M; Kiviniemi T; Airaksinen KE
    Am J Cardiol; 2014 Jul; 114(2):198-205. PubMed ID: 24878127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
    Chang TI; Leong TK; Kazi DS; Lee HS; Hlatky MA; Go AS
    Am Heart J; 2013 May; 165(5):800-8, 808.e1-2. PubMed ID: 23622918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
    Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
    J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hybrid Coronary Revascularization: Early Outcomes and Midterm Follow-Up in Patients Undergoing Single or Multivessel Robotic TECAB and PCI.
    Nisivaco SM; Kitahara H; Abutaleb AR; Nathan S; Balkhy HH
    Innovations (Phila); 2022; 17(6):513-520. PubMed ID: 36529976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Wang TY; McCoy LA; Bhatt DL; Rao SV; Roe MT; Resnic FS; Cavender MA; Messenger JC; Peterson ED
    Am Heart J; 2016 Feb; 172():9-18. PubMed ID: 26856210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.
    Park DW; Ahn JM; Yun SC; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Park SJ
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2813-2822. PubMed ID: 30261236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.